Discontinued — last reported Q2 '24
GE HealthCare Technologies Accrued Manufacturing Costs decreased by 14.9% to $1.42B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.6%, from $1.34B to $1.42B. Over 2 years (FY 2023 to FY 2025), Accrued Manufacturing Costs shows relatively stable performance with a 4.8% CAGR.
accrued_manufacturing_costs| Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $1.52B | $1.24B | $1.42B | $1.52B | $1.34B | $1.36B | $1.54B | $1.67B | $1.42B |
| QoQ Change | — | -18.6% | +15.1% | +7.0% | -11.7% | +1.6% | +13.0% | +8.0% | -14.9% |
| YoY Change | — | — | — | +0.2% | — | +10.4% | +8.4% | +9.5% | +5.6% |